Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR headsets could keep ICU patients mentally clear

NCT ID NCT07357389

Prevention Sponsor: Cedars-Sinai Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether daily 15-minute virtual reality sessions with calming nature scenes and meditation can prevent delirium in high-risk ICU patients. About 822 adults in the surgical ICU at Cedars-Sinai will either get standard care or standard care plus VR for up to 5 days. Researchers will track how many develop delirium, how long it lasts, and whether VR is practical and safe in the ICU.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality (VR) sessions with calming scenes, meditation, and music
What this could lead to
If it works, this could offer a simple, drug-free way to prevent delirium in ICU patients, potentially reducing hospital stays and improving recovery.
What could go wrong
This is an early-stage study testing feasibility and effectiveness. VR may not be practical for all ICU patients, and the benefits may be small or not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 822 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals who are currently admitted to the SICU at Cedars-Sinai Medical Center * Expected ICU stay \>48 hours * Richmond Agitation Sedation Scale (RASS) score between -1 to +2. * CAM-ICU negative * 1≤ risk factor for delirium (Age ≥ 65 years old, history of cognitive impairment, sepsis, Sequential Organ Failure Assessment (SOFA) score \>5, history of alcohol or benzodiazepine abuse, recent major surgery) Exclusion Criteria: * Unwilling and/or unable to participate * Intubation of tracheostomy * Self-reported history of severe motion sickness * Inability to follow commands (e.g. severe aphasia, deafness, GCS\<13) * The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted device (HMD * Those that require corrective lenses -2.5 or stronger that cannot be corrected with contact lenses * Having had a seizure in the past year * Unable to understand the instructions or to consent to participation in the study. * Those who are pregnant * Hemodynamic instability (MAP\<65 despite support) * End-of-life care * Severe agitation or delirium (i.e. CAM-ICU + screen)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Icu delirium are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

delirium prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Icu delirium

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cedars Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.